The company, which was founded in Switzerland and is now co-based in Lausanne and Boston, combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing.
SOPHiA AI enables healthcare professionals to make sense of complex genomic and radiomic data through advanced analysis in order to better diagnose and treat patients, both for oncology and hereditary disorders.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze